Smith & Nephew refused knee revision coverage from insurers
This article was originally published in Clinica
Executive Summary
Smith & Nephew (S&N) has engaged itself in a tussle with two of its product liability insurers after the latter refused to cover the cost of replacement surgery related to S&N's macrotextured cement-free knee implants. While the company is uncertain of the duration and outcome of this dispute, it is nevertheless bracing itself for an £80m ($153m) hit to its year-end profits.